{"nct_id":"NCT03075644","title":"A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2017-03-03","start_date_type":"ACTUAL","primary_completion_date":"2018-10-04","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVO"]}